NASDAQ:BBI

Brickell Biotech Earning Date

USA |NASDAQ |USD

BBI Earnings Date

|
Report Date Period Ending EPS Forecast Last Quarter's EPS Last Year's EPS
Nov 10, 2021 Sep 2021 $-0.12 $-0.16 $-0.15
Report Date Period Ending Revenue Forecast Last Quarter’s Revenue Last Year’s Revenue
Nov 10, 2021 Sep 2021 $150.00K $151.00K $142.00K

Brickell Biotech's next earnings date is Wednesday, Nov 10, 2021 for the fiscal quarter ending Sep 2021.

BBI Earnings Date & History Chart

BBI Earnings & Revenue Forecast

BBI Earnings Forecast

|
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Dec 2021 2 $-0.09 $-0.10 $-0.09
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Dec 2021 2 $-0.52 $-0.54 $-0.50
Dec 2022 2 $-0.28 $-0.29 $-0.27

BBI Earnings Revision Trend

|
Period End Up/Down 1M 1M Trend 2M Trend 3M Trend
Dec 2021 0 / 0 $-0.09 $-0.10 $-0.11
Period End Up/Down 1M 1M Trend 2M Trend 3M Trend
Dec 2021 0 / 0 $-0.52 $-0.52 $-0.50
Dec 2022 0 / 0 $-0.28 $-0.28 $-0.38

BBI Revenue Forecast

|
Period End # of Analysts Revenue Forecast Low Revenue Forecast High Revenue Forecast
Dec 2021 2 $150.00K $0.00 $300.00K
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Dec 2021 2 $500.00K $200.00K $800.00K
Dec 2022 2 $1.40M $0.00 $2.80M

BBI Earnings Date & Revenue History

BBI Earnings History

|
Show More
Show More

BBI Revenue History

|
Show More
Show More

Brickell Biotech Next Earnings Date & Report

BBI Next Earnings Date & Report Preview: Sep 2021 (FQ)

BBI's next earnings date is Wednesday, Nov 10, 2021 for the fiscal quarter ending Sep 30, 2021.

According to 2 analysts, the average EPS estimation for Brickell Biotech's next quarterly earnings is $-0.12, with a low EPS estimation of $-0.14, and a high estimation of $-0.11.

Over the last 1 month, EPS estimates have seen 0 upward revisions and 0 downward. The EPS 1 month trend is $-0.12, the last 2 month trend is $-0.12, and the 3 month trend is $-0.12.

Based on 2 analysts, the average revenue estimation is $150.00K, with a low revenue estimation of $0.00, and a high estimation of $300.00K.

Brickell Biotech Previous Earnings Dates & Reports

BBI Previous Earnings Date & Report Recap: Jun 2021 (FQ)

Brickell Biotech's previous earnings date was Aug 12, 2021 for its fiscal quarter ended Jun 30, 2021.

BBI's earnings per share (EPS) was $-0.16, missing the consensus analysts forecast of $-0.13 by -28.00%.

The EPS was lower than the previous fiscal quarter (Mar 2021) by 6.67%, and higher than the same period a year before (Jun 2020) by -63.06%.

Revenues were $151.00K, better than the forecast of $50.00K by 202.00%, up by 788.24% from the previous quarter , and down by -75.12% from the same period last year.

The company reported a net income of $-11.15M.

Free cash flow for the quarter was $-14.31M , compared to $-5.93M last quarter and $-4.68M a year before.

BBI ended the quarter with $86.00K in total debt, a decrease of -82.41% compared to the previous quarter, and a decrease of -80.32% compared to the same quarter a year before.

BBI Previous Earnings Date & Report Recap: Dec 2020 (FY)

Brickell Biotech's previous annual earnings date was Mar 9, 2021 for its fiscal year ended Dec 31, 2020.

BBI's earnings per share (EPS) was $-1.18, missing the consensus analysts forecast of $-0.71 by 66.72% , and higher than the previous year's EPS (Dec 2019) by -77.50%.

Revenues were $1.82M, worse than the forecast of $2.30M by -20.78%, and down by -76.99% from previous year's revenue.

The company reported a net income of $-20.91M.

Brickell Biotech reported a free cash flow of $-20.06M for its fiscal year, compared to $-35.99M a year ago.

The company ended the fiscal year with $511.00K in total debt, an increase of 238.41% compared to the previous year.